On September 29, 2009
On Yaz, Bayer Believes “a Multiple of a Rare Event Is Still a Rare Event”
The mainstream media has finally woken up to Bayer’s problems on its Yaz contraceptive brands. The New York Times published a story over the weekend about the 74 lawsuits against the company alleging that the pills cause potentially fatal embolisms in users. A close look at recent events at Bayer indicate that the company seems to see the world one way, even though everyone else sees it another.
0 Comments